Current OTC pediatric dosing regimens considered "too broad" by AAP committee.
This article was originally published in The Tan Sheet
CURRENT OTC PEDIATRIC DOSING REGIMENS CONSIDERED "TOO BROAD" by the American Academy of Pediatrics' Committee on Drugs, AAP committee chair Cheston Berlin, MD, told FDA's Nonprescription Drugs Advisory Committee on Jan. 13. Referring to the dosing schedule used for many pediatric cough/cold products, Berlin said the "current dosing approach, we believe, is too broad."
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC